Retatrutide finished its Phase II trials, and Phase III trial results are expected by the beginning of next year
Diabetes Obes Metab 23(2):508519 Shubrook JH, Radin M, Ali SN, Chubb B, DiPietrantonio K, Collings H, Wyn R, Smith M (2022) Preference for type 2 diabetes therapies in the United States: a discrete choice experiment
Some patients on short-term steroids may benefit from temporary dose increases in GLP-1 medication, while those on chronic steroids need stable, ongoing support
Liraglutide begins with doses of 0.6 mg daily, increasing once weekly
The timeline varies depending on injury severity
How to check whether your BCBS plan covers Wegovy The first step in determining if Wegovy is covered by your plan is to check your plan documents